These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3184242)

  • 21. Efficacy of Bacillus thuringiensis var. Kurstaki in the control of two mosquito species (Anopheles stephensi and Culex quinquefasciatus).
    Kumar AS; Moorthi M; Ramakrishnan N; Dhanapakiam P; Ramasamy VK; Rajeswari AR
    J Environ Biol; 2009 May; 30(3):433-5. PubMed ID: 20120473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory and field evaluation of Spherix, a formulation of Bacillus sphaericus (B-101), to control breeding of Anopheles stephensi and Culex quinquefasciatus.
    Mittal PK; Adak T; Batra CP; Sharma VP
    Indian J Malariol; 1993 Jun; 30(2):81-9. PubMed ID: 8405598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a cry4Ba-type gene of Bacillus thuringiensis israelensis and evidence of the synergistic larvicidal activity of its encoded protein with Cry2A delta-endotoxin of B. thuringiensis kurstaki on Culex pipiens (common house mosquito).
    Zghal RZ; Tounsi S; Jaoua S
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):19-25. PubMed ID: 16309381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small scale field trials of Bacillus sphaericus (strain 2362) against anopheline and culicine mosquito larvae in southern Mexico.
    Arredondo-Jiménez JI; López T; Rodríguez MH; Bown DN
    J Am Mosq Control Assoc; 1990 Jun; 6(2):300-5. PubMed ID: 2370538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Bactimos briquets (B.t.i. formulation) combined with the backswimmer Notonecta irrorata (Hemiptera:Notonectidae) for control of mosquito larvae.
    Neri-Barbosa JF; Quiroz-Martinez H; Rodriguez-Tovar ML; Tejada LO; Badii MH
    J Am Mosq Control Assoc; 1997 Mar; 13(1):87-9. PubMed ID: 9152881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Bacillus sphaericus and Bacillus thuringiensis var. israelensis for control of Culex pipiens and floodwater Aedes larvae in Iowa.
    Berry WJ; Novak MG; Khounlo S; Rowley WA; Melchior GL
    J Am Mosq Control Assoc; 1987 Dec; 3(4):579-82. PubMed ID: 3504943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of temperature on toxicity of two bioinsecticides spherix (Bacillus sphaericus) and bactoculicide (Bacillus thuringiensis) against larvae of four vector mosquitoes.
    Mittal PK; Adak T; Sharma VP
    Indian J Malariol; 1993 Mar; 30(1):37-41. PubMed ID: 8100540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mosquito host range and field activity of Bacillus sphaericus isolate 2297 (serotype 25).
    Lacey LA; Lacey CM; Peacock B; Thiery I
    J Am Mosq Control Assoc; 1988 Mar; 4(1):51-6. PubMed ID: 2903904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
    Mittal PK; Adak T; Batra CP
    J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-larvicidal effects of Bacillus thuringiensis israelensis and Bacillus sphaericus on oviposition and adult mortality of Culex quinquefasciatus Say (Diptera: Culicidae).
    Zahiri NS; Mulla MS
    J Vector Ecol; 2005 Jun; 30(1):155-62. PubMed ID: 16007971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Culex family mosquito larva on the sensitivity of Anopheles mosquitos with various karyotypes to the entomopathogenic bacteria Bacillus thuringiensis subsp. Israelensis].
    Gordeev MI; Burlak VA
    Genetika; 1994 Mar; 30(3):367-72. PubMed ID: 8188058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study of the bioactivity of vegetative proteins extracted from Malaysian Bacillus thuringiensis isolates.
    Ramasamy B; Nadarajah VD; Soong ZK; Lee HL; Mohammad SM
    Trop Biomed; 2008 Apr; 25(1):64-74. PubMed ID: 18600206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory and field evaluation of Teknar HP-D, a biolarvicidal formulation of Bacillus thuringiensis ssp. israelensis, against mosquito vectors.
    Gunasekaran K; Doss PS; Vaidyanathan K
    Acta Trop; 2004 Oct; 92(2):109-18. PubMed ID: 15350862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for the introduction of new Bacillus thuringiensis Israelensis products into the routine mosquito control program in Germany.
    Becker N; Rettich F
    J Am Mosq Control Assoc; 1994 Dec; 10(4):527-33. PubMed ID: 7707059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial control of mosquito larvae: investigation of stability of Bacillus thuringiensis var. israelensis and Bacillus sphaericus standard powders.
    Thiery I; Hamon S
    J Am Mosq Control Assoc; 1998 Dec; 14(4):472-6. PubMed ID: 10084145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inactivation by sunlight on the larvicidal activities of mosquitocidal Bacillus thuringiensis H-14 isolates from Nigerian soils.
    Obeta JA
    J Commun Dis; 1996 Jun; 28(2):94-100. PubMed ID: 8810143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel isolate of Bacillus thuringiensis serovar leesis that specifically exhibits larvicidal activity against the moth-fly, Telmatoscopus albipunctatus.
    Higuchi K; Saitoh H; Mizuki E; Hwang SH; Ohba M
    Syst Appl Microbiol; 1998 Mar; 21(1):144-50. PubMed ID: 9741119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of tablets from the crude extract of Rhinacanthus nasutus (Thai local plant) against Aedes aegypti and Culex quinquefasciatus larvae: a preliminary study.
    Rongsriyam Y; Trongtokit Y; Komalamisra N; Sinchaipanich N; Apiwathnasorn C; Mitrejet A
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):265-71. PubMed ID: 17124984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory and field evaluation of two formulations of Bacillus thuringiensis M-H-14 against mosquito larvae in the Islamic Republic of Iran, 2012.
    Gezelbash Z; Vatandoost H; Abai MR; Raeisi A; Rassi Y; Hanafi-Bojd AA; Jabbari H; Nikpoor F
    East Mediterr Health J; 2014 May; 20(4):229-35. PubMed ID: 24952119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae.
    Seleena P; Lee HL; Lecadet MM
    J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.